It had eight biotechnology products on the market, and more than 25 ongoing preclinical and clinical development projects at the end of 2005. Serono Headquarters and the Geneva research site moved to a brand new campus (Horizon Secheron) in the heart of Geneva in 2006. This facility and the headquarters were closed by Merck KGaA in 2013. The building was sold back to Berterelli family. Lawsuit In 2005, Serono agreed to a $704 million settlement with the Department of Justice to resolve civil and criminal allegations that the company engaged in a fraudulent scheme to promote the drug Serostim for off-label uses and paid out illegal kickbacks for prescribing the drug in violation of the False Claims Act. The settlement is, to date, the ninth largest pharmaceutical settlement in U.S. history. Fertility LifeLines Serono provides Fertility LifeLines as a free and confidential source of information to infertility patients. Notes and references 2002 Form 20-F. Retrieved July 3, 2005. 2004 Form 20-F. Retrieved July 3, 2005. See also List of pharmaceutical companies Pharmaceutical industry in Switzerland External links Merck KGaA corporate homepage Serono Pharmaceutical Company Intelligence Selected Company Websites Austria Canada Czech Republic France Germany Greece Italy Israel Japan Korea Switzerland Taiwan USA Merck Group Biotechnology companies of Switzerland Pharmaceutical companies of Switzerland Defunct companies of Switzerland Pharmaceutical companies established in 1906 Manufacturing companies based in Geneva Pharmaceutical companies disestablished in 2006 Biotechnology companies disestablished in 2006 2006 mergers and acquisitions Swiss companies established in 1906 Italian companies established in 1906 Swiss companies disestablished in 2006